All compounds were directed towards targets of interest such as GPCRs, kinases, nuclear receptors, ion channels and transporters.
Analysis using Vertex Kine “2-0” kinase likeness model* shows 27.5% are classified as “kinase-like”.
* Kinase-likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology Alex M. Aronov,* Brian McClain, Cameron Stuver Moody, and Mark A. Murcko. J. Med. Chem. 2008, 51, 1214–1222
Various GPCR finger-printing were used and typically 15-24% of compounds were found to be similar (Tanimoto similarity >0.67 to 0.64) to members of GPCR reference drugs.
One of our customers has filtered the entire collection against their own filters for PPI inhibitors, and selected ~20,000 compounds for screening.
Overall we are unable to share any screening data (e.g. hit-rate in each target class) associated with the compound collection as the information is proprietary of MSD/Schering-Plough/Organon.